Literature DB >> 7537510

Identification of MIP-1 alpha/LD78 as a monocyte chemoattractant released by the HTLV-I-transformed cell line MT4.

R Bertini1, W Luini, S Sozzani, B Bottazzi, P Ruggiero, D Boraschi, D Saggioro, L Chieco-Bianchi, P Proost, J van Damme.   

Abstract

It is known that the HTLV-I-transformed cell line MT4 releases chemotactic activity for monocytes spontaneously. The MT4 monocyte chemoattractant was purified to homogeneity and sequencing of 25 amino acids revealed identity with the C-C chemokine macrophage inflammatory protein-1 alpha (MIP-1 alpha/LD78). An anti-MIP-1 alpha/LD78 rabbit antiserum substantially inhibited chemotaxis of the MT4 chemoattractant. MT4 cells constitutively expressed MIP-1 alpha/LD78 but not the C-C chemokines MCP-1, RANTES, and MIP-1 beta/Act2 and the C-X-C chemokines IL-8, gro alpha, and gro beta. MT4-derived MIP-1 alpha/LD78 was active on monocytes but was a weak chemoattractant for polymorphonuclear leukocytes. Thus, MIP-1 alpha/LD78 is a major monocyte chemoattractant released by HTLV-I-transformed T cells. Expression of MIP-1 alpha/LD78, a leukocyte chemotactic and myelosuppressive molecule, may play an important role in the manifestations of HTLV-I-related diseases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7537510     DOI: 10.1089/aid.1995.11.155

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  4 in total

1.  The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine.

Authors:  P Menten; S Struyf; E Schutyser; A Wuyts; E De Clercq; D Schols; P Proost; J Van Damme
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

2.  Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells.

Authors:  R Bertini; O M Howard; H F Dong; J J Oppenheim; C Bizzarri; R Sergi; G Caselli; S Pagliei; B Romines; J A Wilshire; M Mengozzi; H Nakamura; J Yodoi; K Pekkari; R Gurunath; A Holmgren; L A Herzenberg; L A Herzenberg; P Ghezzi
Journal:  J Exp Med       Date:  1999-06-07       Impact factor: 14.307

Review 3.  The Chemokine System in Oncogenic Pathways Driven by Viruses: Perspectives for Cancer Immunotherapy.

Authors:  Géraldine Schlecht-Louf; Claire Deback; Françoise Bachelerie
Journal:  Cancers (Basel)       Date:  2022-02-08       Impact factor: 6.639

4.  Gene set signature of reversal reaction type I in leprosy patients.

Authors:  Marianna Orlova; Aurélie Cobat; Nguyen Thu Huong; Nguyen Ngoc Ba; Nguyen Van Thuc; John Spencer; Yohann Nédélec; Luis Barreiro; Vu Hong Thai; Laurent Abel; Alexandre Alcaïs; Erwin Schurr
Journal:  PLoS Genet       Date:  2013-07-11       Impact factor: 5.917

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.